PAI-1, t-PA and circulating hTERT DNA as related to virus infection in liver carcinogenesis

Rosa Divella, Rosanna Lacalamita, Stefania Tommasi, Maria Coviello, Antonella Daniele, Vito Michele Garrisi, Ines Abbate, Giovanni Simone, Cosimo Gadaleta, Angelo Paradiso, Michele Quaranta

Research output: Contribution to journalArticlepeer-review


Background: Liver carcinogenesis seems to be heavely influenced by hepatitis B and C viral (HBV, HCV) infection. The aim of our study was to improve the detection of hepatocellular carcinoma (HCC) by measuring alfafetoprotein (AFP) in addition to other molecular markers by estimating the plasma levels of human catalytic fraction of reverse telomerase (hTERT) DNA, plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (t-PA) in 75 patients with liver desease. Patients and Methods: A control group was enrolled (N=30). PAI-1 and t-PA levels were detected with enzyme-linked immunoassorbent assay (ELISA), DNA hTERT was performed with real time polymerase chain reaction (RT-PCR). Results: PAI-1, t-PA and hTERT DNA levels were much higher than in controls. PAI-1 and t-PA levels were higher in the presence of both viruses compared to their absence, p

Original languageEnglish
Pages (from-to)223-228
Number of pages6
JournalAnticancer Research
Issue number1 A
Publication statusPublished - Jan 2008


  • Circulating hTERT DNA
  • Hepatocellular carcinoma
  • PAI-1
  • t-PA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'PAI-1, t-PA and circulating hTERT DNA as related to virus infection in liver carcinogenesis'. Together they form a unique fingerprint.

Cite this